|
|
|
|
|
|
|
Ibio Inc (IBIO)
|
|
0.155 -0.005 (-3.12%)
|
05-24 15:59
|
|
Open:
|
0.165
|
Pre. Close:
|
0.16
|
|
High:
|
0.162
|
Low:
|
0.152
|
|
Volume:
|
521,333
|
Market Cap:
|
18M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
0.17 - 0.171
|
0.171 - 0.172
|
|
Low:
|
0.148 - 0.149
|
0.149 - 0.15
|
|
Close:
|
0.149 - 0.15
|
0.15 - 0.151
|
|
|
|
Technical analysis (as of: 2018-05-24 5:28:54 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 0.19  One year: 0.21
|
|
Support:
|
Support1: 0.14 Support2: 0.12
|
|
Resistance:
|
Resistance1:
0.16 Resistance2: 0.18
|
|
Pivot:
|
0.15 
|
|
Moving Averages:
|
MA(5): 0.15 MA(20): 0.16
MA(100): 0.19 MA(250): 0.26
|
|
MACD:
|
MACD(12,26):
-0.01 Signal(12,26,9): -0.01
|
|
%K %D:
|
%K(14,3): 45.98 %D(3): 44.39
|
|
RSI:
|
RSI(14): 44.97
|
|
52-Week:
|
High: 0.55
Low: 0.14 Change(%): -58.4
|
|
Average Vol(K):
|
3-Month: 107942
10-Days 70368
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.IBIO has closed below upper band by 45.3%. Bollinger Bands are 65.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to IBIO's normal range. The bands have been in this narrow range for 17 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
2017-10-16T13:03:45-04:00
Aethlon deal stokes iBio, shares ahead 7%
2017-10-16T09:27:25-04:00
Premarket Gainers as of 9:05 am
2017-10-16T07:15:00-04:00
Aethlon Medical Announces Large-Scale Production Collaboration
2017-07-25T07:12:00-04:00
AzarGen Biotechnologies Granted European Patent for Plant-Made PRODUCTION OF RECOMBINANT HUMAN SURFACTANT PROTEIN-B
2017-07-12T08:32:00-04:00
US Patent Granted to AzarGen Biotechnologies for Synthetic Promoter Technology
2016-04-12T13:31:23-04:00
InsiderInsights.com Daily Round Up 4/11/16: LIFE, BVSN, TACO, JMP
2016-01-28T13:29:43-05:00
InsiderInsights.com Daily Round Up 1/27/16: Simmons First National, Hooper Holmes, Kinder Morgan, Veeva Systems
2015-04-28T09:12:31-04:00
Premarket Gainers / Losers as of 9:10 am
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
